Inspire Investing’s Amedisys AMED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-3,970
| Closed | -$391K | – | 851 |
|
|
2025
Q2 | $391K | Buy |
3,970
+252
| +7% | +$23.8K | 0.04% | 489 |
|
|
2025
Q1 | $344K | Sell |
3,718
-687
| -16% | -$63.3K | 0.04% | 481 |
|
|
2024
Q4 | $400K | Buy |
4,405
+155
| +4% | +$14.2K | 0.04% | 639 |
|
|
2024
Q3 | $410K | Buy |
4,250
+428
| +11% | +$41.8K | 0.04% | 700 |
|
|
2024
Q2 | $351K | Sell |
3,822
-52
| -1% | -$4.83K | 0.04% | 624 |
|
|
2024
Q1 | $357K | Sell |
3,874
-193
| -5% | -$18.1K | 0.04% | 698 |
|
|
2023
Q4 | $387K | Buy |
4,067
+780
| +24% | +$72.9K | 0.04% | 444 |
|
|
2023
Q3 | $307K | Sell |
3,287
-155
| -5% | -$14.3K | 0.04% | 548 |
|
|
2023
Q2 | $315K | Sell |
3,442
-248
| -7% | -$20.3K | 0.04% | 516 |
|
|
2023
Q1 | $271K | Buy |
3,690
+871
| +31% | +$75.4K | 0.03% | 732 |
|
|
2022
Q4 | $235K | Buy |
2,819
+710
| +34% | +$64K | 0.03% | 556 |
|
|
2022
Q3 | $204K | Buy |
2,109
+105
| +5% | +$12.5K | 0.03% | 721 |
|
|
2022
Q2 | $211K | Buy |
2,004
+637
| +47% | +$81.4K | 0.03% | 628 |
|
|
2022
Q1 | $236K | Sell |
1,367
-124
| -8% | -$18.5K | 0.03% | 467 |
|
|
2021
Q4 | $241K | Sell |
1,491
-19
| -1% | -$3.05K | 0.03% | 769 |
|
|
2021
Q3 | $225K | Buy |
+1,510
| New | +$314K | 0.03% | 695 |
|
|
2021
Q1 | – | Sell |
-1,656
| Closed | -$485K | – | 602 |
|
|
2020
Q4 | $485K | Buy |
+1,656
| New | +$425K | 0.11% | 173 |
|
|
2018
Q1 | – | Sell |
-1,056
| Closed | -$56K | – | 217 |
|
|
2017
Q4 | $56K | Buy |
+1,056
| New | +$55.7K | 0.05% | 523 |
|
Other funds holding AMED
IA
MCI
HNB
Inspire Investing's AMED Position: Q3 2025 in Review
Inspire Investing sold out of Amedisys (AMED) in Q3 2025, closing a stake of 3,970 shares — an estimated $391K sold.
Inspire Investing first reported a position in AMED in Q4 2017 and held it in 18 quarters. The position peaked at $485K in Q4 2020. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.
- Inspire Investing reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
- Inspire Investing sold 3,970 Amedisys shares in Q3 2025, an estimated $391K.
- Inspire Investing first reported a position in Amedisys in Q4 2017 and held it in 18 quarters.
- Inspire Investing's Amedisys position peaked at $485K in Q4 2020.
- 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.
Based on Inspire Investing's 13F filing for Q3 2025, filed 15 Oct 2025.